Literature DB >> 33479671

Substance use disorders: leading the road to recovery.

Emily K Dennis1, Sylvie Garneau-Tsodikova1.   

Abstract

Substance use disorders are diseases of the brain that create a dependency on drug(s), either prescription or illicit. These diseases affect millions of people worldwide, yet, there are few treatments that can help patients in the long term. This opinion piece looks at strategies researchers and institutes are taking to help find treatments as well as at new therapies in clinical trials. It provides an outlook on how a changing public perspective of these diseases can ultimately lead to a brighter outlook for substance use disorder treatments. This journal is © The Royal Society of Chemistry 2020.

Entities:  

Year:  2020        PMID: 33479671      PMCID: PMC7651624          DOI: 10.1039/d0md00161a

Source DB:  PubMed          Journal:  RSC Med Chem        ISSN: 2632-8682


  8 in total

Review 1.  Conjugate Vaccine Immunotherapy for Substance Use Disorder.

Authors:  Paul T Bremer; Kim D Janda
Journal:  Pharmacol Rev       Date:  2017-07       Impact factor: 25.468

Review 2.  Breaking barriers to novel analgesic drug development.

Authors:  Ajay S Yekkirala; David P Roberson; Bruce P Bean; Clifford J Woolf
Journal:  Nat Rev Drug Discov       Date:  2017-06-09       Impact factor: 84.694

Review 3.  Future pharmacological treatments for substance use disorders.

Authors:  Ariadna Forray; Mehmet Sofuoglu
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

4.  New Scaffold for Lead Compounds to Treat Methamphetamine Use Disorders.

Authors:  Na-Ra Lee; Guangrong Zheng; Peter A Crooks; Michael T Bardo; Linda P Dwoskin
Journal:  AAPS J       Date:  2018-02-09       Impact factor: 4.009

Review 5.  Biologics to treat substance use disorders: Current status and new directions.

Authors:  Marco Pravetoni
Journal:  Hum Vaccin Immunother       Date:  2016-07-21       Impact factor: 3.452

6.  Development of Fc-Fused Cocaine Hydrolase for Cocaine Addiction Treatment: Catalytic and Pharmacokinetic Properties.

Authors:  Xiabin Chen; Jing Deng; Wenpeng Cui; Shurong Hou; Jinling Zhang; Xirong Zheng; Xin Ding; Huimei Wei; Ziyuan Zhou; Kyungbo Kim; Chang-Guo Zhan; Fang Zheng
Journal:  AAPS J       Date:  2018-03-19       Impact factor: 4.009

Review 7.  Medications for substance use disorders (SUD): emerging approaches.

Authors:  Eduardo R Butelman; Mary Jeanne Kreek
Journal:  Expert Opin Emerg Drugs       Date:  2017-10-30       Impact factor: 4.191

Review 8.  Public health and international drug policy.

Authors:  Joanne Csete; Adeeba Kamarulzaman; Michel Kazatchkine; Frederick Altice; Marek Balicki; Julia Buxton; Javier Cepeda; Megan Comfort; Eric Goosby; João Goulão; Carl Hart; Thomas Kerr; Alejandro Madrazo Lajous; Stephen Lewis; Natasha Martin; Daniel Mejía; Adriana Camacho; David Mathieson; Isidore Obot; Adeolu Ogunrombi; Susan Sherman; Jack Stone; Nandini Vallath; Peter Vickerman; Tomáš Zábranský; Chris Beyrer
Journal:  Lancet       Date:  2016-03-24       Impact factor: 79.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.